ZNF675 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.552800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.374400E-01
Normal-vs-Stage2
3.609200E-01
Normal-vs-Stage3
2.393800E-01
Normal-vs-Stage4
3.351000E-01
Stage1-vs-Stage2
7.478600E-01
Stage1-vs-Stage3
2.182400E-01
Stage1-vs-Stage4
8.886400E-01
Stage2-vs-Stage3
2.122800E-01
Stage2-vs-Stage4
6.490800E-01
Stage3-vs-Stage4
1.221410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.553600E-01
Normal-vs-AfricanAmerican
3.118400E-01
Normal-vs-Asian
5.207600E-02
Caucasian-vs-AfricanAmerican
3.698400E-01
Caucasian-vs-Asian
2.549600E-01
AfricanAmerican-vs-Asian
2.188600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.523400E-01
Normal-vs-Female
3.621600E-01
Male-vs-Female
7.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.224400E-01
Normal-vs-Age(41-60Yrs)
4.156000E-01
Normal-vs-Age(61-80Yrs)
3.340200E-01
Normal-vs-Age(81-100Yrs)
3.042400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.916800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.147400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.495000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.718500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.275840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.163400E-01
Normal-vs-Daily Drinker
2.974600E-01
Normal-vs-Weekly Drinker
1.280190E-01
Normal-vs-Occasional Drinker
3.789200E-01
Normal-vs-Social Drinker
3.544800E-01
Non Drinker-vs-Daily Drinker
7.035200E-01
Non Drinker-vs-Weekly Drinker
7.265400E-01
Non Drinker-vs-Occasional Drinker
2.919000E-01
Non Drinker-vs-Social Drinker
6.053200E-01
Daily Drinker-vs-Weekly Drinker
5.303200E-01
Daily Drinker-vs-Occasional Drinker
1.726400E-01
Daily Drinker-vs-Social Drinker
4.276600E-01
Weekly Drinker-vs-Occasional Drinker
7.726600E-01
Weekly Drinker-vs-Social Drinker
9.874200E-01
Occasional Drinker-vs-Social Drinker
6.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.949400E-01
Normal-vs-Grade 2
8.127800E-01
Normal-vs-Grade 3
8.091600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.633200E-01
Grade 1-vs-Grade 3
7.657000E-01
Grade 1-vs-Grade 4
7.949400E-01
Grade 2-vs-Grade 3
9.135000E-01
Grade 2-vs-Grade 4
8.127800E-01
Grade 3-vs-Grade 4
8.091600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.352400E-01
Normal-vs-NonDiabetic
3.374600E-01
Diabetic-vs-NonDiabetic
9.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.467800E-01
Normal-vs-NoPancreatitis
3.476400E-01
Pancreatitis-vs-NoPancreatitis
5.276000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.356200E-01
Normal-vs-N1
3.660400E-01
N0-vs-N1
4.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.937200E-01
Normal-vs-TP53-NonMutant
4.443800E-01
TP53-Mutant-vs-TP53-NonMutant
4.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
